{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:05:23Z","timestamp":1759104323910,"version":"3.44.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,12]],"date-time":"2017-08-12T00:00:00Z","timestamp":1502496000000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["31402195","31472195"],"award-info":[{"award-number":["31402195","31472195"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["20140520171JH","20160414029GH"],"award-info":[{"award-number":["20140520171JH","20160414029GH"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004032","name":"Jilin University","doi-asserted-by":"publisher","award":["4305050102TS","450060501486","4305050102S4"],"award-info":[{"award-number":["4305050102TS","450060501486","4305050102S4"]}],"id":[{"id":"10.13039\/501100004032","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chinese Special Fund for Agri-scientific Research in the public interest","award":["201303033"],"award-info":[{"award-number":["201303033"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2013M541313","2016T90261"],"award-info":[{"award-number":["2013M541313","2016T90261"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.antiviral.2016.08.003","type":"journal-article","created":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T15:39:51Z","timestamp":1470411591000},"page":"140-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A Raf kinase inhibitor demonstrates antiviral activities both in\u00a0vitro and in\u00a0vivo against different genotypes of virulent Newcastle disease virus"],"prefix":"10.1016","volume":"133","author":[{"given":"Renfu","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingze","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangyao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhai","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzhang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Stoeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.08.003_bib1","first-page":"95","article-title":"Newcastle disease: progress and gaps in the development of vaccines and diagnostic tools","volume":"135","author":"Afonso","year":"2013","journal-title":"Dev. Biol."},{"key":"10.1016\/j.antiviral.2016.08.003_bib2","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1007\/s00705-014-2148-6","article-title":"Toll-like receptor 3 inhibits Newcastle disease virus replication through activation of pro-inflammatory cytokines and the type-1 interferon pathway","volume":"159","author":"Cheng","year":"2014","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2016.08.003_bib3","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1586\/14787210.2013.845524","article-title":"Delivery of host cell-directed therapeutics for intracellular pathogen clearance","volume":"11","author":"Collier","year":"2013","journal-title":"Expert Rev. anti-infective Ther."},{"key":"10.1016\/j.antiviral.2016.08.003_bib4","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/QCO.0000000000000212","article-title":"The future of antivirals: broad-spectrum inhibitors","volume":"28","author":"Debing","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.08.003_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.antiviral.2011.08.002","article-title":"Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in\u00a0vitro and in\u00a0vivo","volume":"92","author":"Droebner","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.003_bib6","doi-asserted-by":"crossref","first-page":"9439","DOI":"10.1128\/JVI.00533-10","article-title":"The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza A virus and vesicular stomatitis virus propagation by establishing an antiviral state","volume":"84","author":"Dudek","year":"2010","journal-title":"J.\u00a0Virol"},{"key":"10.1016\/j.antiviral.2016.08.003_bib7","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/cmi.12108","article-title":"The NF-kappaB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance","volume":"15","author":"Ehrhardt","year":"2013","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.antiviral.2016.08.003_bib8","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1128\/JVI.02618-05","article-title":"Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines","volume":"80","author":"Krishnamurthy","year":"2006","journal-title":"J.\u00a0Virol"},{"key":"10.1016\/j.antiviral.2016.08.003_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-5793(04)00108-5","article-title":"MEK inhibition impairs influenza B virus propagation without emergence of resistant variants","volume":"561","author":"Ludwig","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.antiviral.2016.08.003_bib10","doi-asserted-by":"crossref","first-page":"14289","DOI":"10.1128\/JVI.02552-14","article-title":"The human cytomegalovirus UL26 protein antagonizes NF-kappaB activation","volume":"88","author":"Mathers","year":"2014","journal-title":"J.\u00a0Virol"},{"key":"10.1016\/j.antiviral.2016.08.003_bib11","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1462-5822.2007.00902.x","article-title":"Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity","volume":"9","author":"Mazur","year":"2007","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.antiviral.2016.08.003_bib12","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1016\/j.vaccine.2007.07.017","article-title":"Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge","volume":"25","author":"Miller","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.08.003_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2011.05.009","article-title":"Inhibition of influenza virus-induced NF-kappaB and Raf\/MEK\/ERK activation can reduce both virus titers and cytokine expression simultaneously in\u00a0vitro and in\u00a0vivo","volume":"92","author":"Pinto","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.003_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF01314327","article-title":"Failure to obtain drug-resistant variants of influenza virus after treatment with inhibiting doses of 3-deazaadenosine and H7","volume":"119","author":"Scholtissek","year":"1991","journal-title":"Arch. Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2016.08.003_bib15","first-page":"24","article-title":"Development, characterization and optimization of a new suspension chicken-induced pluripotent cell line for the production of Newcastle disease vaccine","volume":"44","author":"Shittu","year":"2016","journal-title":"Biol. J. Int. Assoc. Biol. Stand."},{"key":"10.1016\/j.antiviral.2016.08.003_bib16","doi-asserted-by":"crossref","first-page":"7782","DOI":"10.1128\/AAC.01375-15","article-title":"Antiviral activity of broad-spectrum and enterovirus-specific inhibitors against clinical isolates of enterovirus D68","volume":"59","author":"Sun","year":"2015","journal-title":"Antimicrob. agents Chemother."},{"year":"2013","series-title":"Diseases of Poultry","author":"Swayne","key":"10.1016\/j.antiviral.2016.08.003_bib17"},{"key":"10.1016\/j.antiviral.2016.08.003_bib18","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1073\/pnas.0711741105","article-title":"Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity","volume":"105","author":"Tsai","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.08.003_bib19","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1099\/jgv.0.000228","article-title":"Expression of Raf kinase inhibitor protein is downregulated in response to Newcastle disease virus infection to promote viral replication","volume":"96","author":"Yin","year":"2015","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2016.08.003_bib20","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jmb.2011.03.055","article-title":"Human immunodeficiency virus type 1 induces lytic cycle replication of Kaposi's-sarcoma-associated herpesvirus: role of Ras\/c-Raf\/MEK1\/2, PI3K\/AKT, and NF-kB signaling pathways","volume":"410","author":"Zhu","year":"2011","journal-title":"J.\u00a0Mol. Biol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216302078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216302078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:26:16Z","timestamp":1759062376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216302078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":20,"alternative-id":["S0166354216302078"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.08.003","relation":{},"ISSN":["0166-3542"],"issn-type":[{"type":"print","value":"0166-3542"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Raf kinase inhibitor demonstrates antiviral activities both in\u00a0vitro and in\u00a0vivo against different genotypes of virulent Newcastle disease virus","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}